SEAN BRYNJELSEN, President & CEO, Director at Eton Pharmaceuticals, holds 961.19K shares in Eton Pharmaceuticals (Ticker: ETON), holds 9.84K shares in Sagent Pharm (Ticker: SGNT). Most recently, SEAN BRYNJELSEN Sold ― shares of Eton Pharmaceuticals on Aug 20, 2026 for an estimated value of $6.09M.
What is the percentage of profitable transactions made by SEAN BRYNJELSEN?
The percentage of profitable transactions made by SEAN BRYNJELSEN is 38%.
What is the average return per transaction made by SEAN BRYNJELSEN?
The average return per transaction made by SEAN BRYNJELSEN is -19.30%.
What stocks does SEAN BRYNJELSEN hold?
SEAN BRYNJELSEN holds: ETON, SGNT stocks.
What was SEAN BRYNJELSEN’s latest transaction?
SEAN BRYNJELSEN latest transaction was an Informative Sell of $6.09M.
What was SEAN BRYNJELSEN's most profitable transaction?
SEAN BRYNJELSEN’s most profitable transaction was an Informative Buy of ETON stock on September 23, 2022. The return on the trade was 124.10%.
What is SEAN BRYNJELSEN's role in Eton Pharmaceuticals?
SEAN BRYNJELSEN's role in Eton Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.